Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911632 · ClinicalTrials.gov registry record · NA
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
A NA study of Pulmonary Hypertension and Interstitial Lung Disease (ILD), sponsored by Tempus AI.
- Active
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 20
- Study locations
NCT06911632 is a NA study of Pulmonary Hypertension and Interstitial Lung Disease (ILD) that is active but no longer recruiting, run by Tempus AI. The registered enrollment target is 1,000 participants, above the 600-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (67% higher). The trial reports 20 study locations across 17 states.
The verdict
NCT06911632, a NA study of Pulmonary Hypertension and Interstitial Lung Disease (ILD), is active but no longer recruiting, sponsored by Tempus AI.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
Conditions Studied
Interventions
- DEVICE ECG-based AI Device - Results Returned to Investigator
- PROCEDURE Echocardiogram and Right Heart Catheterization
- DEVICE ECG-based AI Device - Results Not Returned to Investigator
Study Locations (20)
Arizona
- Banner University Medical Center - Phoenix
- Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute - Phoenix
Illinois
- Northwestern University - Chicago
- University of Illinois Health - Chicago
Indiana
- Indiana University Health Methodist Hospital - Indianapolis
- Community Health Network - Indianapolis
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- National Jewish Health - Denver
Florida
- AdventHealth Orlando - Orlando
Kentucky
- University of Kentucky - Lexington
Louisiana
- Louisiana State University Health Shreveport - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-07-23 |
| Est. Completion | 2028-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06911632
The ClinicalTrials.gov registry entry for NCT06911632 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 600-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (67% higher). The listed sponsor is Tempus AI, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 3 interventions - of which ECG-based AI Device - Results Returned to Investigator is the first listed.
NCT06911632 reports 20 study locations spanning 17 distinct geographic areas - top geographies include Arizona, Illinois, Indiana.
Frequently Asked Questions
What is clinical trial NCT06911632 about?
NCT06911632 is a clinical study titled "Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension". MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
What is the current status of trial NCT06911632?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-07-23. Estimated completion is 2028-07.
What conditions does trial NCT06911632 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Interstitial Lung Disease (ILD).
What interventions are being tested in trial NCT06911632?
The interventions under investigation include: ECG-based AI Device - Results Returned to Investigator (DEVICE), Echocardiogram and Right Heart Catheterization (PROCEDURE), ECG-based AI Device - Results Not Returned to Investigator (DEVICE).
Who is sponsoring clinical trial NCT06911632?
This trial is sponsored by Tempus AI, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06911632 being conducted?
This trial has 20 study locations across Alabama, Arizona, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and Exercise
RECRUITING · NA
-
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
RECRUITING · NA
-
Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.